FFA Sciences specializes in innovative technologies for measuring unbound free fatty acids (FFA) through their proprietary assay reagents. Their flagship products, ADIFAB and ADIFAB2, are fluorescent probes designed to quantify the aqueous concentration of unbound FFAs in a rapid and straightforward manner, completing measurements in approximately one minute. ADIFAB is suitable for a variety of biochemical and clinical applications, while ADIFAB2 offers enhanced sensitivity for lower concentrations of FFAs, making it ideal for serum or plasma measurements. Both products utilize a simple fluorescence-based method, where the presence of unbound FFAs shifts the fluorescence emission from blue to green, allowing for accurate quantification without the need for extensive calibration.

In addition to their core products, FFA Sciences is actively developing new fluorescent probes with increased specificity for various metabolites, including palmitic and oleic acids. They also offer recombinant rat intestinal fatty acid binding protein (I-FABP) and calibrated aqueous solutions of fatty acids complexed with bovine serum albumin as standards for assay development. The company provides a range of services, including high-throughput screening for drugs affecting FFA metabolism, determining binding affinities, and developing custom assays tailored to specific metabolites. These technologies and services position FFA Sciences as a leader in the field of metabolomics, facilitating advanced research and clinical applications related to fatty acid metabolism.

United States

FFA Sciences produces novel fluorescent probes to measure levels of unbound free fatty acids and other unbound metabolites in fluids. These easy to use reagents require as little as 2 microliters of sample and measurements can be completed in approximately one minute.

FFA Sciences

Company Details